Drugsupdate.com is up for sale. To own one of the most recognized online brands by doctors in India with millions of visitors - click here.
Shilpa Medicare has announced that the company has received EU approval for its Oncology manufacturing unit situated at Deosugur Industrial Area.
The site was inspected by auditors of The French Health Products Safety Agency (AFSSAPS), in march, this year and the plant was found complied with GMP (EU GMP-Part-II) principals for active substance Gemcitabine Hydrochloride.
This fast growing Active Pharmaceuticals Ingredients company, following this approval can market its products in highly regulated markets of all European countries.